Kenvue Stock Falls 10% Amid Autism-Tylenol Link Report

Shares of Kenvue dropped over 10% following reports that HHS Secretary Robert F. Kennedy Jr. will likely link Tylenol use during pregnancy to autism in a forthcoming report, despite Kenvue and major health authorities asserting no causal connection. The report, which may also suggest a folate-derived medicine for autism symptoms, is part of HHS's broader investigation into rising autism rates, though current scientific consensus and regulatory agencies maintain Tylenol's safety when used appropriately during pregnancy.